Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Prijeđi na sadržaj

Lormetazepam

Izvor: Wikipedija
Lormetazepam
Klinički podaci
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 848-75-9
ATC kod N05CD06
PubChem[1][2] 13314
ChemSpider[3] 12750
UNII GU56C842ZA DaY
KEGG[4] D01657 DaY
ChEBI CHEBI:52993 DaY
ChEMBL[5] CHEMBL22097 DaY
Hemijski podaci
Formula C16H12Cl2N2O2 
Mol. masa 335,185
SMILES eMolekuli & PubHem
Sinonimi methyl-lorazepam, N-methyllorazepam
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Lormetazepam je organsko jedinjenje, koje sadrži 16 atoma ugljenika i ima molekulsku masu od 335,185 Da.

Osobine

[uredi | uredi kod]
Osobina Vrednost
Broj akceptora vodonika 3
Broj donora vodonika 1
Broj rotacionih veza 1
Particioni koeficijent[6] (ALogP) 3,7
Rastvorljivost[7] (logS, log(mol/L)) -5,5
Polarna površina[8] (PSA, Å2) 52,9

Stereokemija

[uredi | uredi kod]

Lormetazepam sadrži stereocentar i sastoji se od dva enantiomera. Ovo je racemat, tj. 1: 1 smjesa ( R ) i ( S ) - oblika:[9]

Enantiomeri lormetazepama

CAS-Nummer: 113679-56-4

CAS-Nummer: 113679-54-2

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  7. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573. 
  8. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286. 
  9. Rote Liste Service GmbH (Hrsg.): Rote Liste 2017 – Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und bestimmter Medizinprodukte). Rote Liste Service GmbH, Frankfurt/Main, 2017, Aufl. 57, ISBN 978-3-946057-10-9, S. 196.

Literatura

[uredi | uredi kod]

Spoljašnje veze

[uredi | uredi kod]